Cefirone V 1000 mg/500 mg Injection
By Cefirone V
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Vancomycin(500mg)

Manufacturer - Abbott
16th Floor, Godrej BKC, Plot – C, "G" Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Expires on or after
October, 2025

liver
Cefirone V 1000 mg/500 mg Injection should be used cautiously in individuals with severe liver problems. It may be necessary to adjust the dosage of Cefirone V 1000 mg/500 mg Injection in such cases. It is important to consult your doctor regarding the appropriate dosage. However, dose adjustment of Cefirone V 1000 mg/500 mg Injection is generally not advised for patients with mild to moderate liver disease. Please seek medical advice for proper guidance before using Cefirone V 1000 mg/500 mg Injection.

kidney
Cefirone V 1000 mg/500 mg Injection should be used carefully in patients with kidney disease. Dose adjustment may be required. Consult your doctor and have regular kidney function and blood tests during treatment.

alcohol
When using Cefirone V 1000 mg/500 mg Injection, there are no harmful side effects when drinking alcohol.

driving
Cefirone V 1000 mg/500 mg Injection may reduce alertness, impact vision, cause drowsiness, and dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Cefirone V 1000 mg/500 mg Injection may not be safe to use during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Cefirone V 1000 mg/500 mg Injection is likely safe during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹390
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025